checkAd

    Medacta Group SA  109  0 Kommentare Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023

    Für Sie zusammengefasst
    • Medacta Group SA revenues up +19.5% at constant currency in FY 2023.
    • Strong growth in EMEA, APAC, and North America.
    • Positive contributions from every business line, with excellent results in Knee and Shoulder.

    Medacta Group SA / Key word(s): Sales Result
    Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023

    02-Feb-2024 / 07:00 CET/CEST
    Release of an ad hoc announcement pursuant to Art. 53 LR
    The issuer is solely responsible for the content of this announcement.


    Press Release – Ad-hoc announcement pursuant to Art. 53 LR                          

    Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of Euro 500Mln in FY 2023 

    • FY 2023 revenue increased to Euro 510.8 million, or 19.5% c.c.1 (16.8% reported) from FY 2022;
    • Strongest growth occurred in EMEA with very good performance in APAC and North America;
    • Positive contributions from every business line with excellent results in Knee and Shoulder;
    • Robust supply chain key to enabling the accelerated growth;
    • Strong focus maintained on Medical Education;
    • 193 new jobs created, including salesforce expansion surpassing 1'700 employees at Group level.

    CASTEL SAN PIETRO, 2 February 2024 – Medacta Group SA (“Medacta”, SIX:MOVE) announces today the full year 2023 preliminary unaudited revenue.

    Francesco Siccardi, CEO of Medacta, commented: “We conclude another year with outstanding growth. Our strong commitment to innovate responsibly and sustainably, through minimally invasive techniques and personalized solutions remains one of the key pillars of our successful strategy. Our comprehensive offer and ongoing investments to support continuous growth will allow us to face the challenges that lie ahead in 2024, marking our 25th anniversary.

    In 2023 we delivered solid organic growth, with a significant gain of new customers across all geographies and business lines. On top of the effective commercial development, we experienced some tailwind thanks to the recovery of the accumulated backlog mainly in USA and Australia.

    Supply chain remains a key factor for our success, and in this regard, we launched two main projects to support our future plans: the inauguration of a new distribution center in Memphis for the US market and the expansion of our manufacturing plants in Switzerland.

    Seite 1 von 6



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Medacta Group SA Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023 Medacta Group SA / Key word(s): Sales Result Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023 02-Feb-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. …